Other languages Vanda Pharmaceuticals Inc.

Equities

VNDA

US9216591084

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-07 pm EDT			5-day change	1st Jan Change
6.12 ^USD	-2.39%		+19.77%	+45.02%

Jun. 06	Sector Update: Health Care Stocks Higher in Late Afternoon Trading	MT
Jun. 06	Sector Update: Health Care Stocks Advance Thursday Afternoon	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sector Update: Health Care Stocks Higher in Late Afternoon Trading	Jun. 06
Sector Update: Health Care Stocks Advance Thursday Afternoon	Jun. 06
Sector Update: Health Care	Jun. 06
Vanda Pharmaceuticals' Shares Rally After Company Receives $466 Million Buyout Offer From Cycle Pharma	Jun. 06
Cycle Pharmaceuticals Offers to Buy Vanda Pharmaceuticals for $466 Million	Jun. 06
Top Premarket Gainers	Jun. 06
Vanda Pharmaceuticals to Commercialize Treatment of Multiple Sclerosis in the US	May. 31
Wall Street et la City ne répondent plus	May. 27
En Direct des Marchés : Alstom, TotalEnergies, Thales, Atos, Renault, Julius Bär, Tesla...	May. 27
Borsa di Italia: Wall Street e la City non rispondono più	May. 27
IN DIRETTA DAI MERCATI: Azimut, Stellantis, Generali, Leonardo, Mediobanca, Poste Italiane, Recordati, BBVA, Microsoft, Tesla, TSMC, UBS...	May. 27
Bolsa de Madrid: Wall Street y la City ya no responden	May. 27
Vanda Pharmaceuticals rejects Future Pak's revised takeover offer	May. 24
Vanda Pharmaceuticals rejects Future Pak's deal	May. 24
Future Pak, Ltd. cancelled the acquisition of Vanda Pharmaceuticals Inc. from The Vanguard Group, Inc., Renaissance Technologies LLC, BlackRock, Inc., Butler Hall Capital LLC, Shareholder Capital LLC and others.	May. 23
Vanda Pharmaceuticals Says Second Phase 3 Study of Tradipitant in Motion Sickness Yields 'Positive' Results	May. 15
Vanda Pharmaceuticals Inc. Reports Positive Results from A Second Phase III Study of Tradipitant in Motion Sickness	May. 15
Vanda Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 08
Sector Update: Health Care Stocks Advance in Late Afternoon Trading	May. 07
Sector Update: Health Care Stocks Stronger in Tuesday Afternoon Trading	May. 07

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Vanda Pharmaceuticals Inc.

Equities

VNDA

US9216591084

Other languages

Filters